COVID-19: a new emerging respiratory disease from the neurological perspective

被引:0
|
作者
Amr El-Sayed
Lotfi Aleya
Mohamed Kamel
机构
[1] Cairo University,Department of Medicine and Infectious Diseases, Faculty of Veterinary Medicine
[2] Bourgogne Franche-Comté University,Chrono
关键词
ACE2 receptors; COVID-19; MERS; Neurological signs; SARS-CoV-2;
D O I
暂无
中图分类号
学科分类号
摘要
Coronavirus disease 2019 (COVID-19) has become a challenging public health catastrophe worldwide. The newly emerged disease spread in almost all countries and infected 100 million persons worldwide. The infection is not limited to the respiratory system but involves various body systems and may lead to multiple organ failure. Tissue degenerative changes result from direct viral invasion, indirect consequences, or through an uncontrolled immune response. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spreads to the brain via hematogenous and neural routes accompanied with dysfunction of the blood–brain barrier. The involvement of the central nervous system is now suspected to be among the main causes of death. The present review discusses the historical background of coronaviruses, their role in previous and ongoing pandemics, the way they escape the immune system, why they are able to spread despite all undertaken measures, in addition to the neurological manifestations, long-term consequences of the disease, and various routes of viral introduction to the CNS.
引用
收藏
页码:40445 / 40459
页数:14
相关论文
共 50 条
  • [21] Technology acceptance and COVID-19: a perspective for emerging opportunities from crisis
    Abbas, Ansar
    Ekowati, Dian
    Suhariadi, Fendy
    Anwar, Aisha
    Fenitra, Rakotoarisoa Maminirina
    TECHNOLOGY ANALYSIS & STRATEGIC MANAGEMENT, 2024, 36 (11) : 3551 - 3563
  • [22] COVID-19 and the neurological disease therapeutic pipeline
    Jicha, Gregory A.
    Abner, Erin L.
    NATURE REVIEWS NEUROLOGY, 2021, 17 (02) : 71 - 72
  • [23] COVID-19 and the neurological disease therapeutic pipeline
    Gregory A. Jicha
    Erin L. Abner
    Nature Reviews Neurology, 2021, 17 : 71 - 72
  • [24] CLINICAL CHARACTERISTICS OF NEUROLOGICAL DISEASE AND COVID-19
    Thakkar, Kajal
    Goldberg, Alan
    Gomez, Joanne
    Suboc, Tisha Marie
    de lavallaz, Jeanne Du Fay
    Bouroukas, Athina
    Volgman, Annabelle S.
    Williams, Kim Allan, Sr.
    Aggarwal, Neelum T.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2022, 79 (09) : 2122 - 2122
  • [25] Emerging potential mechanisms and predispositions to the neurological manifestations of COVID-19
    Jesuthasan, Aaron
    Massey, Flavia
    Manji, Hadi
    Zandi, Michael S.
    Wiethoff, Sarah
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2021, 428
  • [26] Molecular overlaps of neurological manifestations of COVID-19 and schizophrenia from a proteomic perspective
    Antunes, Andre S. L. M.
    Reis-de-Oliveira, Guilherme
    Martins-de-Souza, Daniel
    EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE, 2025, 275 (01) : 109 - 122
  • [27] New insights into the neurological effects of COVID-19
    Wood, Heather
    NATURE REVIEWS NEUROLOGY, 2020, 16 (08) : 403 - 403
  • [28] New insights into the neurological effects of COVID-19
    Heather Wood
    Nature Reviews Neurology, 2020, 16 : 403 - 403
  • [29] Neurological Manifestations of COVID-19 in Absence of Respiratory Symptoms or Fever
    Mohamed, Abbas
    Qureshi, Ahmad S.
    Mohamed, Sarah A.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (03)
  • [30] Long-Term Respiratory and Neurological Sequelae of COVID-19
    Wang, Fuzhou
    Kream, Richard M.
    Stefano, George B.
    MEDICAL SCIENCE MONITOR, 2020, 26